TC
ROIV icon

Tejara Capital’s Roivant Sciences ROIV Stock Holding History

Tejara Capital’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-506,095
Closed -$7.66M – 71
2025
Q3 		$7.66M Buy
506,095
+43,082
+9% +$533K 3.99% 8
2025
Q2 		$5.22M Sell
463,013
-422,649
-48% -$4.58M 2.42% 10
2025
Q1 		$8.94M Buy
885,662
+72,112
+9% +$780K 3.45% 4
2024
Q4 		$9.62M Sell
813,550
-607,440
-43% -$7.18M 6.3% 2
2024
Q3 		$16.4M Sell
1,420,990
-762,953
-35% -$8.69M 7.81% 1
2024
Q2 		$23.1M Sell
2,183,943
-416,352
-16% -$4.56M 8.39% 1
2024
Q1 		$27.4M Buy
2,600,295
+465,400
+22% +$5.02M 10.07% 1
2023
Q4 		$24M Buy
2,134,895
+1,776,323
+495% +$17.3M 10.04% 1
2023
Q3 		$4.19M Buy
358,572
+118,665
+49% +$1.34M 2.37% 14
2023
Q2 		$2.42M Buy
239,907
+18,461
+8% +$165K 1.19% 27
2023
Q1 		$1.63M Buy
+221,446
New +$1.82M 0.84% 35

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Tejara Capital's ROIV Position: Q4 2025 in Review

Tejara Capital sold out of Roivant Sciences (ROIV) in Q4 2025, closing a stake of 506,095 shares — an estimated $7.66M sold.

Tejara Capital first reported a position in ROIV in Q1 2023 and held it in 11 quarters. The position peaked at $27.4M in Q1 2024. 399 funds tracked by Wall St. Rank hold ROIV as of Q4 2025.

  • Tejara Capital reported no remaining Roivant Sciences position as of Q4 2025 after selling out during the quarter.
  • Tejara Capital sold 506,095 Roivant Sciences shares in Q4 2025, an estimated $7.66M.
  • Tejara Capital first reported a position in Roivant Sciences in Q1 2023 and held it in 11 quarters.
  • Tejara Capital's Roivant Sciences position peaked at $27.4M in Q1 2024.
  • 399 funds tracked by Wall St. Rank held Roivant Sciences as of Q4 2025.

Based on Tejara Capital's 13F filing for Q4 2025, filed 5 Feb 2026.